title: In vivo evaluation of a novel dexamethasone-heparin-double-coated stent for inhibition of artery restenosis and thrombosis.
abstract: To evaluate the efficacy and safety of dexamethasone-heparin-double-coated stent (DHDCS) on inhibition of artery lumen reduction and neointimal hyperplasia in porcine model we carried out this study. Bare mental stents (BMS, n = 12), protein-coated stents (PCS, n = 12), heparin microballoon-coated stents (HMCS, n = 12), and DHDCS (n = 12), prepared by the spray drying method, were implanted into the selected internal iliac artery, external iliac artery, sacrococcygeal artery, and femoral artery of each of the selected pigs (n = 12), which were randomly divided into four groups on average. Thirty days and ninety days after the implantation, aorta angiography was performed on all the 12 mini-pigs to evaluate the artery lumen reduction. Subsequently, in order to analyze their histological appearance, the pigs were killed, and their arteries with the stents inside were taken out, embedded in plastic for hard histological section and hematoxylin-eosin (H.E.) staining, and examined by light microscopy and scanning electron microscopy (SEM). The artery lumen reduction and average neointimal hyperplasia in the group of DHDCS were significantly lesser than those in the other three groups of BMS, PCS, and HMCS. This study shows that DHDCS is capable of inhibiting the proliferation of intima and lumen area reduction of the target artery within stents, and effectively and safely reducing the incidence of regional thrombosis and restenosis for a short term.
authors.affiliation: Department of Cardio-Thoracic Surgery, Shanghai No. 6 People Hospital Affiliated Shanghai Jiaotong University School of Medicine, No. 600 Yishan Road, Shanghai 200233, China.
authors.forename: Qing-Kui
authors.initials: QK
authors.lastname: Guo
authors.forename: Zhi-Qian
authors.initials: ZQ
authors.lastname: Lu
authors.forename: Jin-Ye
authors.initials: JY
authors.lastname: Wang
authors.forename: Tao
authors.initials: T
authors.lastname: Li
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000494:pharmacology; D000925:Anticoagulants / Q000008:administration & dosage; D001807:Blood Vessel Prosthesis; D020099:Coated Materials, Biocompatible / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D003907:Dexamethasone / Q000008:administration & dosage* / Q000494:pharmacology; D054855:Drug-Eluting Stents; D006083:Graft Occlusion, Vascular / Q000517:prevention & control*; D006493:Heparin / Q000008:administration & dosage* / Q000494:pharmacology; D008297:Male; D008422:Materials Testing; D008863:Microspheres; D008954:Models, Biological; D013552:Swine; D013927:Thrombosis / Q000517:prevention & control*
chemical_list: D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D020099:Coated Materials, Biocompatible; D003907:Dexamethasone; D006493:Heparin